Elanco Announces Restructuring; To Eliminate Approx. 350 Positions

Elanco Animal Health Incorporated (ELAN) announced restructuring initiative which include the consolidation of R&D activities to align capabilities to the newly combined innovation portfolio to support the company's IPP strategy. The company expects to record charges of between $58 million to $77 million in connection with this restructuring. Elanco expects to recognize between $58 million to $70 million of the total restructuring costs in the first quarter.

Elanco intends to close R&D sites in Manukau, New Zealand and Cuxhaven, Germany. The company will also reduce duplication and optimize structures in U.S. operations, Marketing, Manufacturing and Quality central functions, and administrative areas. The restructuring will result in the elimination of approximately 350 positions.

Elanco increased and tightened its 2021 guidance. Adjusted earnings per share is now expected in a range of $0.86 to $0.96, revised from $0.83 to $0.95.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Deutsche Post DHL Group were gaining around 6 percent in the morning trading in Germany after the package delivery and logistic major reported Friday higher profit and revenues in its second quarter with strong demand. Going ahead, the company confirmed its 2022 EBIT guidance of 8.0 billion euros, plus or minus 5 percent, even in consideration of a possible global economic downturn. Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday net income for the first quarter halved from last year, hurt by a 1 decline in revenues and a decrease in the market prices of its equity investments in publicly-traded companies. Shares of Deutsche Lufthansa AG were gaining around 6 percent in the morning trading after the German flag carrier reported Thursday a profit in its second quarter, compared to last year's loss, benefited by surge in demand. The company also specified its outlook for the year, and now expects adjusted EBIT to be above 500 million euros for the full year of 2022, in line with current market.
Follow RTT